Items where authors include "Burman, J."

Article

Greco, R. orcid.org/0000-0002-6117-5328, Alexander, T., Del Papa, N. et al. (23 more authors) (2024) Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee. eClinicalMedicine, 69. 102476. ISSN 2589-5370

Kalincik, T., Sharmin, S., Roos, I. et al. (150 more authors) (2023) Comparative effectiveness of autologous hematopoietic stem cell transplant vs fingolimod, natalizumab, and ocrelizumab in highly active relapsing-remitting multiple sclerosis. JAMA Neurology, 80 (7). pp. 702-713. ISSN 2168-6149

Alexander, T., Snowden, J.A. orcid.org/0000-0001-6819-3476, Burman, J. et al. (11 more authors) (2021) Intestinal microbiome in hematopoietic stem cell transplantation for autoimmune diseases : considerations and perspectives on behalf of Autoimmune Diseases Working Party (ADWP) of the EBMT. Frontiers in Oncology, 11. 722436.

Das, J. orcid.org/0000-0002-9166-4624, Snowden, J.A. orcid.org/0000-0001-6819-3476, Burman, J. et al. (10 more authors) (2021) Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with ‘aggressive’ multiple sclerosis. Multiple Sclerosis Journal, 27 (8). pp. 1198-1204. ISSN 1352-4585

Greco, R., Alexander, T., Burman, J. et al. (24 more authors) (2021) Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations. Bone Marrow Transplantation, 56. pp. 1493-1508. ISSN 0268-3369

Roberts, F., Hobbs, H., Jessop, H. et al. (15 more authors) (2020) Rehabilitation before and after autologous haematopoietic stem cell transplantation (AHSCT) for patients with multiple sclerosis (MS): Consensus guidelines and recommendations for best clinical practice on behalf of the autoimmune diseases working party, nurses group, and patient advocacy committee of the European Society for Blood and Marrow Transplantation (EBMT). Frontiers in Neurology, 11. 556141. ISSN 1664-2295

Sharrack, B., Saccardi, R., Alexander, T. et al. (15 more authors) (2020) Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases : updated guidelines and recommendations from the EBMT autoimmune diseases working party (ADWP) and the joint accreditation committee of EBMT and ISCT (JACIE). Bone Marrow Transplantation, 55 (2). pp. 283-306. ISSN 0268-3369

Burt, R.K., Balabanov, R., Burman, J. et al. (20 more authors) (2019) Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis: a randomized clinical trial. Journal of the American Medical Association, 321 (2). pp. 165-174. ISSN 0098-7484

Snowden, J.A. orcid.org/0000-0001-6819-3476, Badoglio, M., Labopin, M. et al. (20 more authors) (2017) Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases. Blood Advances, 1 (27). pp. 2742-2755. ISSN 2473-9529